Literature DB >> 16425253

N-Myc functions in transcription and development.

Peter J Hurlin1.   

Abstract

N-Myc is a member of the Myc family of proteins, which are best known for their potent oncogenic activities and association with a large proportion of human cancers. Intense scrutiny of the oncogenic properties of Myc family proteins over the last several decades has revealed a great deal about their transcriptional and oncogenic activities. Myc proteins have broad effects on transcription and can stimulate a variety of cell behaviors that contribute to the malignant phenotype. N-Myc and c-Myc also play essential functions during embryonic development, and loss of these proteins has deleterious effects in most, if not all, tissues and organ systems. What remains to be fully unraveled is the relationship between the diverse activities associated with deregulated and overexpressed Myc and their normal roles during embryonic development and tissue homeostasis. In this review I summarize our understanding of the transcriptional activities of Myc family proteins and the roles of N-myc in morphogenesis, particularly as they relate to cellular proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425253     DOI: 10.1002/bdrc.20059

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  23 in total

1.  Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression.

Authors:  Elaine L Shelton; Katherine E Yutzey
Journal:  Dev Biol       Date:  2006-10-03       Impact factor: 3.582

2.  N-myc controls proliferation, morphogenesis, and patterning of the inner ear.

Authors:  Elena Domínguez-Frutos; Iris López-Hernández; Victor Vendrell; Joana Neves; Micaela Gallozzi; Katja Gutsche; Laura Quintana; James Sharpe; Paul S Knoepfler; Robert N Eisenman; Andreas Trumpp; Fernando Giráldez; Thomas Schimmang
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

3.  Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear.

Authors:  Benjamin Kopecky; Peter Santi; Shane Johnson; Heather Schmitz; Bernd Fritzsch
Journal:  Dev Dyn       Date:  2011-03-29       Impact factor: 3.780

Review 4.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  Differential regulation of N-Myc and c-Myc synthesis, degradation, and transcriptional activity by the Ras/mitogen-activated protein kinase pathway.

Authors:  Katannya Kapeli; Peter J Hurlin
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

6.  Myocardial Mycn is essential for mouse ventricular wall morphogenesis.

Authors:  Cristina Harmelink; Yin Peng; Paige DeBenedittis; Hanying Chen; Weinian Shou; Kai Jiao
Journal:  Dev Biol       Date:  2012-10-12       Impact factor: 3.582

7.  MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.

Authors:  Constanza Cortés; Sara C Kozma; Albert Tauler; Santiago Ambrosio
Journal:  Cell Oncol (Dordr)       Date:  2015-08-26       Impact factor: 6.730

8.  Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation.

Authors:  Risto Kerkela; Lisa Kockeritz; Katrina Macaulay; Jibin Zhou; Bradley W Doble; Cara Beahm; Sarah Greytak; Kathleen Woulfe; Chinmay M Trivedi; James R Woodgett; Jonathan A Epstein; Thomas Force; Gordon S Huggins
Journal:  J Clin Invest       Date:  2008-10-01       Impact factor: 14.808

9.  Myocardial smad4 is essential for cardiogenesis in mouse embryos.

Authors:  Lanying Song; Wensheng Yan; Xinbin Chen; Chu-xia Deng; Qin Wang; Kai Jiao
Journal:  Circ Res       Date:  2007-06-21       Impact factor: 17.367

10.  Upstream ORF affects MYCN translation depending on exon 1b alternative splicing.

Authors:  Roger Besançon; Sandrine Valsesia-Wittmann; Clara Locher; Céline Delloye-Bourgeois; Lydie Furhman; Giovani Tutrone; Christophe Bertrand; Anne-Catherine Jallas; Elisabeth Garin; Alain Puisieux
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.